TaiwanJ Pharmaceuticals Co (ROCO:6549) YoY EBITDA Growth : -143.01% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is TaiwanJ Pharmaceuticals Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. TaiwanJ Pharmaceuticals Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -143.01%.

TaiwanJ Pharmaceuticals Co's EBITDA per Share for the six months ended in Dec. 2023 was NT$-0.23.

TaiwanJ Pharmaceuticals Co YoY EBITDA Growth Historical Data

The historical data trend for TaiwanJ Pharmaceuticals Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiwanJ Pharmaceuticals Co YoY EBITDA Growth Chart

TaiwanJ Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

109.56

-272.84

78.93

-74.59

89.20

TaiwanJ Pharmaceuticals Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															17.34	-215.53	58.48	268.91	-143.01

TaiwanJ Pharmaceuticals Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

TaiwanJ Pharmaceuticals Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.023	-	-0.213)	/	\| -0.213 \|
=	89.20 %

TaiwanJ Pharmaceuticals Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-0.226	-	-0.093)	/	\| -0.093 \|
=	-143.01 %

TaiwanJ Pharmaceuticals Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of TaiwanJ Pharmaceuticals Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiwanJ Pharmaceuticals Co Ltd (ROCO:6549) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rm. D207, Number 2, Sec.2, ShengYi Road, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei, TWN, 30261

Website

http://www.taiwanj.com

TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Headlines

No Headlines